Recent

% | $
Quotes you view appear here for quick access.

công ty Genomic Health Message Board

  • terry_amln terry_amln Oct 2, 2012 12:31 PM Flag

    Cowen outperform also $43

    Cowen started coverage on shares of Genomic Health (NASDAQ: GHDX) in a research report released on Tuesday morning. The firm issued an outperform rating on the stock.
    GHDX has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase reiterated a neutral rating on shares of Genomic Health in a research note to investors on Thursday, September 27th. Separately, analysts at Credit Suisse initiated coverage on shares of Genomic Health in a research note to investors on Monday, September 24th. They set an outperform rating and a $43.00 price target on the stock

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GHDX
27.11-0.23(-0.84%)Jul 2 4:00 PMEDT